On January 31, 2024, the Board of Core Laboratories Inc. approved a cash dividend of $0.01 per share of common stock payable on March 4, 2024 to shareholders of record on February 12, 2024.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
18.42 USD | -2.18% | +1.43% | +4.30% |
Apr. 25 | Transcript : Core Laboratories Inc., Q1 2024 Earnings Call, Apr 25, 2024 | |
Apr. 24 | Earnings Flash (CLB) CORE LABORATORIES Reports Q1 Revenue $129.6M, vs. Street Est of $124.5M | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.30% | 883M | |
+14.64% | 16.9B | |
0.00% | 8.01B | |
-10.70% | 2.74B | |
-26.80% | 1.81B | |
-5.20% | 1.14B | |
-6.97% | 1.06B | |
-13.45% | 810M | |
+0.62% | 753M | |
-23.45% | 691M |
- Stock Market
- Equities
- CLB Stock
- News Core Laboratories Inc.
- Core Laboratories Inc. Approves Cash Dividend, Payable on March 4, 2024